CXXC4 and acute myeloid leukemia: In contrast, HDAC inhibition with MS275 ignited inflammatory signaling while inhibiting the proliferative signatures in control and ELANE mutant cells, recapitulating the signaling profiles of Cxxc4 mutant mouse AML cells and SCN-AML patient material (Figures 7A and 7B; data not shown).